Autosomal Dominant Tubulointerstitial Kidney Disease

Slide 1 · Autosomal Dominant

Tubulointerstitial Kidney Disease

Genetic classification · tubular compartments · clinicopathologic interpretation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain the name change from medullary cystic kidney disease to ADTKD.

Connect four implicated genes to their encoded proteins or functions.

Interpret nonspecific renal findings and progressive adult-onset dysfunction.

Recognize important limits of morphology, genetic detection, and mechanistic knowledge.

Slide 3 · ADTKD: The defining description

A hereditary renal disease transmitted in an autosomal dominant pattern.

Grouped with tubulointerstitial disorders rather than defined by a single cyst pattern.

Produces progressive renal failure during adult life.

Clinical and pathologic abnormalities are nonspecific.

Slide 4 · What each word in ADTKD contributes

Autosomal

Inheritance not tied to a sex chromosome

→

Dominant

Vertical familial transmission

→

Tubulointerstitial

Principal disease category

→

Kidney disease

Progressive loss of renal function

This descriptive name is more durable than an imaging-only label.

Slide 5 · Tubules and interstitium act together

Robbins groups tubular and interstitial damage because they commonly coexist.

Tubular epithelium performs transport; Adjacent interstitium supports the renal microenvironment.

Disease involving one compartment can produce injury in the other.

The general anatomic category does not specify a unique microscopic ADTKD lesion.

Slide 6 · Primary compartment ≠ exclusive compartment

Early/primary emphasis

A disease can be classified by the compartment in which it starts.

Tubular dysfunction may predominate before advanced structural damage.

With chronic progression

The interstitium, glomeruli, and vasculature may become secondarily affected.

Late-stage kidney changes can obscure the initiating lesion.

Slide 7 · The older name: “medullary cystic kidney disease”

Earlier terminology placed cyst location and cyst formation at the center of the label.

Robbins explicitly replaces this historical name with ADTKD.

The new term foregrounds inherited tubulointerstitial disease.

A historical label in an old record should not be treated as a distinct current diagnosis.

Slide 8 · Why “cystic” is an unreliable gatekeeper

What the textbook establishes

Cysts have variable presence in ADTKD.

Some affected kidneys therefore need not show cysts.

What the reader must avoid

Do not rule out ADTKD solely because no cyst is mentioned.

Do not use cyst presence as a specific molecular marker.

Slide 9 · Why “medullary” is an unreliable locator

Observed naming problem

When cysts are present, they are often not in the medulla.

The historical location-specific label can mislead.

Diagnostic consequence

Avoid inferring an obligatory medullary distribution.

Separate lesion location from the underlying inherited category.

Slide 10 · A nomenclature correction, not a new pathway

Historical descriptor

Medullary cystic kidney disease

→

Observed mismatch

Cysts variable; Location not reliably medullary

→

Genetic framing

Distinct inherited associations

→

Preferred term

ADTKD

The term has changed because the former morphology-based name was insufficient.

Slide 11 · Inherited renal disease: What is actually known

Transmission is described as autosomal dominant.

Multiple genes can be associated with a similar broad clinical category.

Adult renal failure can emerge despite a familial pattern.

Robbins does not provide gene-specific penetrance or progression rates in this section.

Slide 12 · Autosomal dominant inheritance: Concept

An illustrative autosomal dominant family pattern

I

II-1

II-2

II-3

Vertical clustering can support dominant inheritance; The diagram alone does not establish a molecular diagnosis.

Slide 13 · How to read a family history

Findings that increase suspicion

Kidney disease recurring over generations.

Adult relatives with progressive renal functional decline.

Findings that do not prove the cause

Unspecified “kidney disease” in a relative.

A dominant-looking pedigree without an established pathogenic variant.

Slide 14 · Adult renal failure is the longitudinal signal

Progressive renal failure in adult life.

“Progressive” implies a time dimension, not an isolated abnormal result.

End-stage or rapidly declining function at a single visit does not establish the original etiology.

Do not infer age at onset, median ESKD age, or a rate of decline from this excerpt.

Slide 15 · Interpreting progressive dysfunction

Initial evaluation

Recognize renal impairment

→

Longitudinal data

Confirm ongoing deterioration

→

Family pattern

Assess potential heredity

→

Etiologic analysis

Consider ADTKD among alternatives

A clinical reasoning sequence—not a validated diagnostic rule or test threshold.

Slide 16 · Nonspecific clinical findings

Positive textbook statement

ADTKD produces nonspecific clinical findings.

Progressive renal failure is emphasized.

Implication for interpretation

No unique symptom is established in this excerpt.

Symptoms alone cannot select a particular ADTKD gene.

Slide 17 · Nonspecific pathologic findings

Positive textbook statement

ADTKD produces nonspecific pathologic findings.

The passage does not provide a pathognomonic microscopic lesion.

Implication for interpretation

Histology should not be overinterpreted as subtype-specific.

A pathology report requires clinical and genetic context.

Slide 18 · What the ADTKD paragraph does not establish

No diagnostic sensitivity or specificity for renal biopsy or imaging.

No mandatory pattern of cysts, glomerular changes, or basement-membrane abnormalities.

No gene-specific clinical timelines or treatment recommendations.

No resolved common pathogenic mechanism.

Slide 19 · Genes named by Robbins

Gene

Encoded product / role

Stated renal localization

MUC1

Mucin-1

Distal nephrons

UMOD

Uromodulin

Thick ascending limb

REN

Preprorenin

Juxtaglomerular apparatus

HNF1B

HNF1β transcription factor

Controls multiple genes, including UMOD

Slide 20 · MUC1: Molecular identity

The MUC1 gene encodes mucin-1.

Mucin-1 expression in distal nephron segments.

This identifies a protein and an anatomic context.

The passage does not establish an exact MUC1 injury pathway.

Slide 21 · MUC1: Locate the distal-nephron clue

REGULATORY ROLE

CORTEX

MEDULLA

REN

Juxtaglomerular apparatus

MUC1

Distal nephron

UMOD

Thick ascending limb

HNF1B

Transcription factor

Schematic location/function map; Not a scaled renal specimen

Slide 22 · MUC1: Evidence versus extrapolation

Supported association

MUC1 mutations are associated with ADTKD.

Mucin-1 expression is described in distal nephrons.

Unsupported from this section

A specific cellular toxicity sequence.

A unique biopsy stain pattern or age-of-onset prediction.

Slide 23 · UMOD: Molecular identity

The UMOD gene encodes uromodulin.

Uromodulin is expressed in the thick ascending limb of the loop of Henle.

The thick ascending limb is therefore the anatomical expression clue.

Gene association does not itself describe every pathologic mechanism.

Slide 24 · UMOD: Thick ascending limb highlighted

REGULATORY ROLE

CORTEX

MEDULLA

REN

Juxtaglomerular apparatus

MUC1

Distal nephron

UMOD

Thick ascending limb

HNF1B

Transcription factor

Schematic location/function map; Not a scaled renal specimen

Slide 25 · REN: Molecular identity

The REN gene encodes preprorenin.

Robbins localizes expression to the juxtaglomerular apparatus.

The locus and expressed protein differ from the MUC1 and UMOD examples.

The excerpt does not specify the manner by which REN variants damage the kidney.

Slide 26 · REN: Juxtaglomerular expression

REGULATORY ROLE

CORTEX

MEDULLA

REN

Juxtaglomerular apparatus

MUC1

Distal nephron

UMOD

Thick ascending limb

HNF1B

Transcription factor

Schematic location/function map; Not a scaled renal specimen

Slide 27 · REN: Do not confuse physiologic role with proven disease mechanism

Established in the excerpt

REN → preprorenin.

Expression: Juxtaglomerular apparatus.

Not established here

A particular renin concentration profile.

A universal clinical blood-pressure pattern or therapy.

Slide 28 · HNF1B: Molecular identity

The HNF1B gene encodes hepatocyte nuclear factor 1β.

The protein is a transcription factor.

It regulates multiple genes, including UMOD.

A transcriptional regulator is not simply another nephron-segment protein.

Slide 29 · HNF1B: A regulatory level, not a duct label

REGULATORY ROLE

CORTEX

MEDULLA

REN

Juxtaglomerular apparatus

MUC1

Distal nephron

UMOD

Thick ascending limb

HNF1B

Transcription factor

Schematic location/function map; Not a scaled renal specimen

Slide 30 · HNF1B–UMOD: Documented regulatory relationship

HNF1B

Encodes transcription factor HNF1β

→

Regulatory activity

Controls expression of multiple genes

→

UMOD

One explicitly named regulated gene

This is a gene-regulatory link, not proof of a complete injury cascade.

Slide 31 · Direct expression versus transcriptional control

Location-first genes

MUC1: Distal nephron.

UMOD: Thick ascending limb.

REN: Juxtaglomerular apparatus.

Regulatory factor

HNF1B: Transcription factor.

Its stated role spans multiple downstream genes.

Slide 32 · Four loci, one broad disease category

MUC1

Mucin-1

→

UMOD

Uromodulin

→

REN

Preprorenin

→

HNF1B

Transcription factor HNF1β

The common clinical label does not imply identical gene products or a proven shared pathway.

Slide 33 · Anatomic expression: Three locations + one regulator

REGULATORY ROLE

CORTEX

MEDULLA

REN

Juxtaglomerular apparatus

MUC1

Distal nephron

UMOD

Thick ascending limb

HNF1B

Transcription factor

Schematic location/function map; Not a scaled renal specimen

Slide 34 · Molecular clues: Do not interchange

Question

Answer from Robbins

Which product belongs to MUC1?

Mucin-1

Which gene encodes uromodulin?

UMOD

Where is preprorenin expressed?

Juxtaglomerular apparatus

Which factor regulates UMOD?

HNF1B

Slide 35 · Genetic heterogeneity is integral to ADTKD

ADTKD with four named genes.

Different molecular starting points occur under a common diagnostic category.

The affected protein or regulatory role can differ between families.

A phenotype-based label need not identify the causal locus.

Slide 36 · “Almost half” lack a detectable mutation

Exact source claim

Almost half of ADTKDs do not have a detectable mutation.

The passage does not state a test platform or cohort.

Interpretation guardrails

Avoid converting “almost half” to an exact population estimate.

Do not claim that a negative result disproves inherited disease.

Slide 37 · A negative molecular result is not a clinical exclusion

Clinical picture

Hereditary progressive renal disease may still be suspected

→

Molecular result

No mutation detected

→

Correct conclusion

Etiology remains unresolved—not automatically absent

No diagnostic algorithm or assay-performance estimate is asserted.

Slide 38 · Known association versus unknown pathogenesis

What is identified

Genes and encoded products.

Anatomic expression or transcriptional role.

Dominant inheritance and progressive adult renal failure.

What remains unresolved

The pathogenic mechanisms are described as unknown.

A unified molecular-to-histologic causal sequence is not provided.

Slide 39 · Do not fill the mechanistic gap with arrows

Gene association

ADTKD-linked variant

→

Protein context

Product and expression site known

→

Mechanism

Unknown in this source

→

Outcome

Progressive renal failure

Conceptual chain with a deliberate knowledge gap; Not a verified pathway.

Slide 40 · How strong is each level of evidence?

Association: A gene is listed among those implicated in ADTKD.

Localization: The corresponding protein is expressed in a named renal compartment.

Regulation: HNF1B controls multiple genes including UMOD.

Mechanism: The ADTKD paragraph explicitly states that this remains unknown.

Slide 41 · A nonspecific biopsy can still be clinically important

It may establish

Presence and extent of renal tissue damage.

A chronic tubulointerstitial pattern, if actually observed.

It cannot establish from this source alone

A particular ADTKD gene.

A pathognomonic ADTKD histology pattern.

Slide 42 · Tubular dysfunction: General parent-chapter context

Tubulointerstitial disorders can impair urinary concentrating ability.

They may show polyuria, nocturia, salt wasting, or acid excretion defects.

These are general features of the tubulointerstitial disease group.

Robbins does not require any individual feature to diagnose ADTKD.

Slide 43 · Distinguishing tubular from glomerular syndromes

General tubulointerstitial context

Absence of classic nephritic/nephrotic syndromes is a group-level hallmark.

Tubular functional defects may be subtle.

Limits of classification

Advanced diseases of either origin may look similar.

Neither absence of nephrotic syndrome nor nocturia proves ADTKD.

Slide 44 · Case 1: Family history changes the frame

CLINICOPATHOLOGIC VIGNETTE

An adult has slowly progressive renal impairment. A parent and an older sibling also developed chronic kidney disease.

What clue justifies considering an inherited tubulointerstitial disorder?

The vertical family history strengthens suspicion; No single gene can yet be assigned.

Slide 45 · Case 2: No cysts reported

CLINICOPATHOLOGIC VIGNETTE

An adult with progressive renal dysfunction has a family history compatible with dominant inheritance, but renal imaging does not describe cysts.

Does that observation exclude ADTKD?

No. Cysts as variably present; Absence cannot be an absolute exclusion.

Slide 46 · Case 3: Biopsy lacks a signature

CLINICOPATHOLOGIC VIGNETTE

A renal biopsy shows chronic damage described by the pathologist as nonspecific. Several relatives have progressive kidney disease.

Is the negative histologic specificity decisive?

No. Nonspecific pathological findings are part of the textbook ADTKD description.

Slide 47 · Case 4: Genetic result unresolved

CLINICOPATHOLOGIC VIGNETTE

A family with a clinically suggestive dominant pattern has a molecular evaluation that identifies no mutation.

Which conclusion is most defensible from the textbook?

Unresolved molecular cause. No detectable mutation in almost half of cases.

Slide 48 · Case 5: Incidental cyst and unrelated renal decline

CLINICOPATHOLOGIC VIGNETTE

A patient has a single cyst described on imaging and progressive kidney dysfunction without a clear family history.

Can the cyst alone establish ADTKD?

No. Cyst detection is neither a necessary nor a sufficient disease-specific marker.

Slide 49 · ADTKD versus nephronophthisis

Dimension

ADTKD

Nephronophthisis

Inheritance

Autosomal dominant

Familial forms usually autosomal recessive

Typical clinical era

Progressive renal failure in adult life

Usually childhood/adolescence

Cyst description

Variable; not always medullary

Often corticomedullary/medullary

Genetic category

MUC1, UMOD, REN, HNF1B listed

Nephrocystin / ciliopathy genes described

Slide 50 · ADTKD versus medullary sponge kidney

ADTKD

Hereditary, autosomal dominant renal disorder.

Progressive adult renal failure is emphasized.

Cysts may be absent or nonmedullary.

Medullary sponge kidney

Cystic dilation of medullary collecting ducts.

Usually discovered radiographically in adults.

Renal function is usually normal.

Slide 51 · ADTKD versus classic adult polycystic kidney disease

ADTKD

No obligatory large cyst burden in the disease definition.

Cysts can vary in presence and distribution.

Autosomal dominant polycystic kidney disease

Markedly enlarged kidneys with numerous cysts.

A macrocystic gross pattern is a different diagnostic starting point.

Slide 52 · Other chronic tubulointerstitial contexts

Competing context

Clue described by Robbins

Chronic pyelonephritis / reflux

History of infection/reflux; distorted calyces and scars

Drug-related interstitial disease

Drug exposure and immune or cumulative toxic injury

Urate nephropathy

Urate deposition and tubulointerstitial injury

Nephrocalcinosis

Calcium deposition with impaired concentrating ability

ADTKD

Dominant inheritance; listed genetic associations

Slide 53 · Etiologic reasoning when the morphology is nonspecific

Renal course

Chronic, progressive dysfunction

→

Family inquiry

Multiple affected generations?

→

Exclude alternatives

Infection, drug, metabolic context

→

Molecular context

Consider implicated genes; Acknowledge gaps

Interpretive framework only. Not a formally validated clinical diagnostic algorithm.

Slide 54 · Case 6: A segment is not a diagnosis

CLINICOPATHOLOGIC VIGNETTE

An exam question states that a patient has an ADTKD-associated UMOD variant and asks which nephron segment expresses the product.

What is the source-supported answer?

The thick ascending limb of the loop of Henle.

Slide 55 · Case 7: Distinguish product from regulator

CLINICOPATHOLOGIC VIGNETTE

A molecular report names HNF1B. A trainee labels it as the protein made by UMOD.

What is the correction?

HNF1B encodes a transcription factor; It regulates multiple genes, including UMOD.

Slide 56 · Case 8: Renal failure timing

CLINICOPATHOLOGIC VIGNETTE

An adult develops progressive renal dysfunction. The family pedigree is consistent with dominant transmission; Biopsy changes are nonspecific.

Which combination is compatible with the textbook ADTKD profile?

Adult progressive renal failure + autosomal dominant pattern + nonspecific findings.

Slide 57 · Four exam-level gene–product associations

If the prompt mentions…

Recall…

MUC1

Mucin-1; distal nephron

UMOD

Uromodulin; thick ascending limb

REN

Preprorenin; juxtaglomerular apparatus

HNF1B

Transcription factor; regulates UMOD among other genes

Slide 58 · Diagnostic pitfalls that change the answer

Using absence of cysts to rule out ADTKD.

Treating an affected medulla as required by the old name.

Claiming pathognomonic biopsy morphology despite the stated nonspecific findings.

Interpreting an undetected mutation as proof against the diagnosis.

Presenting a hypothetical molecular mechanism as established.

Slide 59 · The defensible ADTKD mental model

Inheritance

Autosomal dominant

→

Course

Progressive renal dysfunction in adults

→

Genetics

Several implicated genes; Many undetected

→

Evidence limit

Nonspecific findings; Pathogenesis unresolved

Use a convergent interpretation—not a single imaging, histology, or test gate.

Slide 60 · Five source-anchored conclusions

ADTKD supersedes the historic medullary cystic kidney disease label.

Cysts are variably present and frequently not medullary.

MUC1, UMOD, REN, and HNF1B are implicated.

Almost half lack a detectable mutation account.

Adult progressive renal failure occurs with nonspecific findings; Mechanisms are unknown.

Slide 61 · References and evidence boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026).

The ADTKD passage establishes nomenclature, genetic associations, inheritance, and adult progression.

Renal disease comparisons draw on the surrounding tubulointerstitial and cystic-disease discussions.

Illustrative pedigrees, vignettes and reasoning flows are educational schematics, not patient observations.

The supplied source gives no ADTKD-specific microscopy or current testing guideline; neither is fabricated here.